Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Chinese Journal of Experimental Ophthalmology
>
2017
>
35
>
4
Volume:
35
Issue:
4
1. Effects of Rho associated kinase inhibitors on glaucoma and current researches
Page:381—384
2. Central nervous system changes in glaucoma
Page:377—380
3. Research progress of awareness of glaucoma
Page:372—376
4. Research progress of Ahmed glaucoma valve implantation in the treatment of neovascular glaucoma
Page:368—371
5. Early clinical outcomes of small incision lenticule extraction for different refractive myopia and astigmatism
Page:349—354
6. Agreement of intraocular pressure measured by noncontact tonometer and Goldmann applanation tonometer : a Meta-analysis
Page:339—343
7. Assessment of microperimetry on fixation stability changes in glaucomatous eyes with hemifield defect
Page:332—338
8. Expression changes of transforming growth factor-β1 and fibronectin in bovine trabecular meshwork cells cultured by iris pigment particles
Page:320—324
9. Induction of transforming growth facor-β2 to the expression of lysyl oxidases in human Tenon capsule fibroblasts in vitro
Page:314—319
10. Co-expression of GRP78 and Myocilin in trabecular meshwork cells of primary open angle glaucoma
Page:300—305
11. Role of glaucoma drainage device implantation in the treatment of refractory glaucoma
Page:362—367
12. Diagnostic capability of ganglion cell complex thickness in primary open angle glaucoma
Page:355—361
13. Dynamic assessment of tear-film stability-associated objective vision in mild or moderate dry eyes based on Optical Quality Analysis System parameters
Page:344—348
14. Inflammatory mechanism and significance of tumor necrosis factor-α and interleukin-1β in pathogenesis of conjunctivochalasis
Page:325—331
15. Effect comparison of laser peripheral iridoplasty at different sites of iris in pigment rabbit glaucoma
Page:307—313
16. Apoptosis and autophagy of retinal ganglion cell-5 cells induced by hydrostatic pressure
Page:293—298
17. The precise personal management is expected to glaucoma neuroprotection
Page:289—292